Glutamine metabolism and radiosensitivity: Beyond the Warburg effect

Area of Science:

• Oncology
• Cancer Metabolism
• Radiotherapy

Background:

• Cancer cell metabolism is a viable therapeutic target for halting disease progression.
• Radiation therapy is a cornerstone of cancer treatment, but radioresistance is a challenge.
• Metabolism-based therapeutics are increasingly combined with radiotherapy to improve outcomes.

Purpose of the Study:

• To review the role of glutamine metabolism in cancer growth and progression.
• To explore how glutamine metabolism inhibition can sensitize cancer cells to radiation.
• To discuss the potential of glutamine antagonism as a synergistic therapy with radiotherapy.

Main Methods:

• Literature review focusing on glutamine metabolism in cancer.
• Analysis of preclinical data on glutamine inhibition and radiosensitization.
• Discussion of mechanisms linking glutamine metabolism to cancer progression.

Main Results:

• Glutamine metabolism influences DNA damage repair, oxidative stress, epigenetic modification, and immune modulation in cancer.
• Inhibition of glutamine utilization demonstrates radiosensitizing effects in preclinical cancer models.
• Glutamine metabolism plays a critical role in driving cancer growth and progression.

Conclusions:

• Glutamine metabolism is a key driver of cancer growth and progression through multiple pathways.
• Inhibiting glutamine metabolism can enhance cancer cell sensitivity to radiation therapy.
• Clinical investigation is warranted to assess glutamine antagonism as a combination therapy with radiotherapy.